AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE Drug Patent Profile
When do Aminess 5.2% Essential Amino Acids W/ Histadine patents expire, and what generic alternatives are available?
Aminess 5.2% Essential Amino Acids W/ Histadine is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE is amino acids. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminess 5.2% Essential Amino Acids W/ Histadine
A generic version of AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE was approved as amino acids by B BRAUN on April 13th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE?
- What are the global sales for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE?
- What is Average Wholesale Price for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE?
Summary for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE at DailyMed |
US Patents and Regulatory Information for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE | amino acids | INJECTABLE;INJECTION | 018901-001 | Apr 6, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
